In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: Results from SMART (Study for Monitoring Antimicrobial Resistance Trends)

Surgical Infections

Volumn 7, Issue 6, 2006, Pages 537-545

  Bochicchio, Grant V ^a   Baquero, Fernando ^b   Hsueh, Po Ren ^c   Paterson, David L ^d   Rossi, Flávia ^e   Snyder, Theresa A ^f   Mccarroll, Kathleen ^f   Satishchandran, Vilas ^f   Dinubile, Mark J ^f   Chow, Joseph W ^f  

^a UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLAVULANIC ACID; ERTAPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN;

ABDOMINAL INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; DRUG SENSITIVITY; ESCHERICHIA COLI; GEOGRAPHIC DISTRIBUTION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BILIARY TRACT; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PERITONEAL CAVITY; POPULATION SURVEILLANCE; WORLD HEALTH;

EID: 33847347380     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.7.537     Document Type: Article

References (12)

1. Felmingham D, Grüneberg RN. A multicenter collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project. J Antimicrob Chemother 1996;38(Suppl A):1-57.
2. Pfaller, MA, Jones RN, Doern GV, et al. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998;42:1762-1770.
3. Turner PJ, Greenhalgh JM, Edwards JR, et al. The MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) programme. Int J Antimicrob Agents 1999;13:117-125.
4. Jones RN, Masterton R. Determining the value of antimicrobial surveillance programs. Diagn Microbiol Infect Dis 2001;41:171-175.
5. Felmingham D. The need for antimicrobial resistance surveillance. J Antimicrob Chemother 2002;50(Suppl S1):1-7.
6. Paterson DL, Rossi F, Baquero F, et al. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: The 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother 2005;55:965-973.
7. Chow JW, Satishchandran V, Snyder TA, Harvey CM, Friedland IR, DiNubile MJ. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: The 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg Infect 2005;6:439-448.
8. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Sixth Edition: Approved Standard M7-A6. Villanova, Pennsylvania. NCCLS, 2003.
9. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing - Thirteenth Informational Supplement. Supplemental Tables M100-S13. Villanova, Pennsylvania. NCCLS, 2003.
10. Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med 1985;4:213-226.
11. Lautenbach E, Strom BL, Nachamkin I, et al. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: Differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis 2004;38:655-662.
12. Livermore DM, James D, Reacher M, et al. Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg Infect Dis 2002;8:473-478.